None listed
Conditions
Interventions
Others(Sugar-sweetened beverages and artificially sweetened beverages) : - This study is a randomized crossover intervention study. Participants will be assigned to two intervention conditions in a ra
Sponsors
Korea Food Research Institute
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: - Individuals with a BMI between 18.5 and <35 kg/m² (ranging from normal weight to pre–severe obesity) - Individuals able to provide blood, urine, stool, and saliva samples - Individuals who consumed sugar-sweetened or artificially sweetened beverages (based on a 250 mL serving, combined across both types) no more than once per day (i.e., =7 times per week) over the past 3 months - Individuals with no objection to wearing a continuous glucose monitoring device twice for 15 days each on a soft, non-muscular area on the back of the upper arm
Exclusion criteria
Exclusion criteria: - Women who are pregnant or breastfeeding - Individuals with specific food allergies - Individuals with skin inflammation or dermatological conditions - Individuals scheduled to undergo medical procedures involving strong magnetic or electromagnetic radiation during the study period (e.g., MRI, CT scan) - Individuals with gastrointestinal disorders that limit the consumption of carbonated beverages or with phenylketonuria that restricts the intake of artificially sweetened beverages - Patients with glucose–galactose malabsorption or diabetes insipidus - Patients with hypersensitivity or a history of allergy to Sunset Yellow FCF (Yellow No. 5) or Tartrazine (Yellow No. 4) - Individuals who have taken antibiotics within the past 3 months - Individuals with a body weight change of =10% within the past 3 months, or currently following a controlled diet for weight management - Individuals who have participated in another clinical trial within the past 3 months involving administration of an investigational product or dietary intervention - Individuals diagnosed with alcohol dependence - Individuals requiring dietary restrictions due to diseases such as diabetes, hypertension, cardiovascular disease, kidney disease, gastrointestinal disease, fatty liver, or thyroid disorders - Individuals requiring continuous blood glucose management or currently receiving pharmacological treatment such as antidiabetic drugs or insulin - Individuals taking medications that may affect body weight - Individuals presenting with acute illness (e.g., fever) at the set-up visit or baseline visit (study start date) - Individuals with a history of major gastrointestinal surgery (except cholecystectomy or appendectomy) or bowel resection within the past 6 months - Individuals with uncontrolled active gastrointestinal diseases or disorders - Individuals with a history of cardiovascular diseases (e.g., heart failure, myocardial infarction, stroke), renal diseases (e.g., chronic kidney failure, nephrotic syndrome), pulmonary diseases (e.g., asthma, chronic obstructive pulmonary disease), or hepatitis B or C - Individuals with a history of cancer, except for localized resected squamous cell carcinoma or basal cell carcinoma of the skin
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Gut and oral microbiome composition | — |
Secondary
| Measure | Time frame |
|---|---|
| Postprandial glycemic responses to sugar-sweetened and artificially sweetened beverage consumption;Postprandial glycemic responses under meal conditions including sugar-sweetened and artificially sweetened beverages | — |
Countries
Korea, Republic of
Contacts
Public ContactSangwon Chung
Korea Food Research Institute
Outcome results
None listed